Perspective: a program to improve protein biomarker discovery for cancer

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Biomarker Discovery

Background:

• Protein biomarkers are vital for cancer risk assessment, early detection, prognosis, and predicting therapeutic response.
• Their diversity and physiological roles present significant potential for revolutionizing cancer management.
• Current challenges hinder the full realization of protein biomarker applications.

Purpose of the Study:

• To outline an effective program for discovering protein biomarkers using existing technologies.
• To identify key components and technological advancements needed for successful biomarker discovery.
• To emphasize the importance of protein biomarkers in advancing cancer care.

Main Methods:

• Utilizing team science and an integrated informatics platform.
• Identifying and quantifying candidate biomarkers in disease tissues and mouse models.
• Developing standardized reagents and implementing automation for biomarker analysis in bodily fluids.

Main Results:

• An effective program necessitates a multidisciplinary approach combining biology, informatics, and engineering.
• Technological improvements in proteome fractionation, biomarker selection, and multiplexed assays are essential.
• Standardized reagents and automation are critical for reliable biomarker detection.

Conclusions:

• A comprehensive strategy integrating team science, informatics, and advanced technology is required for protein biomarker discovery.
• Further technological innovation in proteomic analysis and assay development will accelerate progress in cancer management.
• Successful implementation of protein biomarker programs promises to significantly improve patient outcomes through enhanced cancer care.